Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04636190 · ClinicalTrials.gov registry record · NA

Triathlon All-Polyethylene Tibia Outcomes Study

A NA study of Knee Arthritis and Arthropathy of Knee, sponsored by Stryker Orthopaedics.

Active
Registry status
NA
Development phase
204
Enrollment target
6
Study locations

NCT04636190 is a NA study of Knee Arthritis and Arthropathy of Knee that is active but no longer recruiting, run by Stryker Orthopaedics. The registered enrollment target is 204 participants, above the 112-participant average among 7 other Knee Arthritis trials with a reported enrollment target (82% higher). The trial reports 6 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04636190, a NA study of Knee Arthritis and Arthropathy of Knee, is active but no longer recruiting, sponsored by Stryker Orthopaedics.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
204 participants
Enrollment target
6
Study locations

Study Summary

The purpose of this study is to evaluate the clinical functional results of the Triathlon All-Polyethylene Tibia Knee Device.

Interventions

  • DEVICE Triathlon All-Polyethylene Tibia Knee

Study Locations (6)

New York

  • Kaleida Health, Department of Orthopaedic Surgery, Buffalo General Hospital - Buffalo
  • Syracuse Orthopedic Specialists, PC - Syracuse

Michigan

  • Michigan Orthopaedic Center - Lansing

North Carolina

  • Duke University Medical Center - Durham

Ohio

  • Department of Orthopaedic Surgery Cleveland Clinic - Cleveland

Texas

  • Musculoskeletal Institute, University of Texas Health Austin - Austin

Trial Details

FieldValue
Enrollment Target 204 participants
Start Date 2021-07-02
Est. Completion 2033-10
Phase NA

Sponsor

Stryker Orthopaedics

27 total trials

What the Registry Record Tells You About NCT04636190

The ClinicalTrials.gov registry entry for NCT04636190 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 204 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 112-participant average among 7 other Knee Arthritis trials with a reported enrollment target (82% higher). The listed sponsor is Stryker Orthopaedics, which has 27 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Knee Arthritis appearing as the primary indexed condition, and to 1 intervention - of which Triathlon All-Polyethylene Tibia Knee is the first listed.

NCT04636190 reports 6 study locations spanning 5 distinct geographic areas - top geographies include New York, Michigan, North Carolina.

Frequently Asked Questions

What is clinical trial NCT04636190 about?

NCT04636190 is a clinical study titled "Triathlon All-Polyethylene Tibia Outcomes Study". The purpose of this study is to evaluate the clinical functional results of the Triathlon All-Polyethylene Tibia Knee Device.

What is the current status of trial NCT04636190?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 204 participants. The study started on 2021-07-02. Estimated completion is 2033-10.

What conditions does trial NCT04636190 study?

This clinical trial studies the following conditions: Knee Arthritis, Arthropathy of Knee, Replacement.

What interventions are being tested in trial NCT04636190?

The interventions under investigation include: Triathlon All-Polyethylene Tibia Knee (DEVICE).

Who is sponsoring clinical trial NCT04636190?

This trial is sponsored by Stryker Orthopaedics, which has 27 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04636190 being conducted?

This trial has 6 study locations across Michigan, New York, North Carolina, Ohio, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Knee Arthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.